Statement Of Changes In Equity [Abstract]

Exosens - Filing #5981339

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	—	—	10 378 EUR	—	—	—	342 537 EUR	—	21 583 EUR	1 965 EUR	412 601 EUR	—	56 895 EUR	—	—	204 065 EUR	12 917 EUR	26 215 EUR	—	—	—	—	188 052 EUR	—	1 948 EUR	768,000 EUR	204 066 EUR	7 808 EUR	14 961 EUR	188 059 EUR	1 941 EUR	206,000 EUR	183 053 EUR
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	30 680 EUR	0 EUR	—	30 680 EUR	0 EUR	0 EUR	—	0 EUR	—	—	—	30 680 EUR	—	18 407 EUR	18 407 EUR	—	—	—	18 407 EUR	0 EUR	0 EUR	0 EUR	—	0 EUR	—	—	—	—	—	—	—	—	—
Other comprehensive income	0 EUR	29,000 EUR	—	1 226 EUR	0 EUR	0 EUR	—	1 197 EUR	—	—	—	1 226 EUR	—	626,000 EUR	0 EUR	—	—	—	626,000 EUR	64,000 EUR	0 EUR	562,000 EUR	—	0 EUR	—	—	—	—	—	—	—	—	—
Comprehensive income	30 680 EUR	29,000 EUR	—	31 906 EUR	0 EUR	0 EUR	—	1 197 EUR	—	—	—	31 906 EUR	—	19 032 EUR	18 407 EUR	—	—	—	19 033 EUR	64,000 EUR	0 EUR	562,000 EUR	—	0 EUR	—	—	—	—	—	—	—	—	—
Issue of equity	0 EUR	0 EUR	—	192 162 EUR	19 757 EUR	172 405 EUR	—	0 EUR	—	—	—	1,922,000,000 EUR	—	—	0 EUR	—	—	—	0 EUR	0 EUR	6,000 EUR	0 EUR	—	6,000 EUR	—	—	—	—	—	—	—	—	—